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Abstract 
A 21 year-old woman with Prader-Willi syndrome 
(PWS) and a delusional disorder (paranoid psychosis) is 
described. Other reports of psychoses associated with 
PWS are reviewed. Reasons for the co-existence of the 
two disorders are considered, with discussion of the 
possible role of auditory information processing deficits 
in the genesis of psychotic symptoms. Such symptoms 
must be differentiated from maladaptive behaviours not 
arising from psychosis, the latter being relatively 
common in PWS. Treatment with a small dose of 
flupenthixol greatly reduced the impact of the patient's 
psychotic symptoms, with a corresponding improvement 
in her quality of life. 
Key words: Prader-Willi syndrome; Psychiatry; Psychoses; 
Genetics: behavioural aspects; Mental retardation. 
Introduction 
Prader-Willi syndrome is a developmental disorder char-
acterised by neonatal hypotonia and feeding difficulty, 
followed by a switch to marked over-eating which occurs 
during early childhood. Affected adults are of short stature, 
have a characteristic facial appearance and small hands and 
feet, and hypogonadism. Most are obese, but dietary 
management from childhood may avoid the extreme obesity 
which has previously been characteristic of the condition. 
Cognitive impairment is usual, but not all affected people 
have cognitive and social impairments which are so severe 
as to constitute mental retardation.'2 The majority of people 
with the disorder (about 60%) have a paternally-derived 
deletion of the long arm of chromosome 15 at q l l - q l 3 . 
Other abnormalities which may occur include maternal 
disomy (the inheritance of two number 15 chromosomes 
from the mother), translocations (with associated deletions) 
and rearrangements of material on 15q. PWS is thought to 
result from the lack of a paternally derived contribution to 
the relevant area of chromosome 15, and genomic imprint-
ing has been suggested as a mechanism through which 
uniparental disomy could result in the disorder.34 
PWS is associated with a variety of maladaptive behav-
iours in addition to extreme hyperphagia. These include 
temper tantrums, self-injury through picking at skin, resis-
tance to change, sleep problems, and oppositional/defiant or 
'stubborn' behaviour.510 Some of these maladaptive behav-
iours have been considered so characteristic of PWS that 
they have been incorporated into diagnostic criteria." 
In the course of research into behavioural aspects of PWS, 
three people with PWS and psychoses were described.12 A 
further case has now been assessed, and is reported here. 
Case report 
E was born in 1972. She has a twin brother and an older 
sister. She had the extreme neonatal hypotonia and feeding 
difficulty which are characteristic of PWS, although the 
diagnosis was not made until she was 19 years old. She 
developed hyperphagia during childhood and consequently 
gained weight. There is no family history of learning disabil-
ity or of psychiatric illness. 
At the age of 20 E moved to her current residential place-
ment, a rehabilitation facility which aims to improve the 
daily living skills and communicatory ability of people with 
learning disabilities. Although E had, like many people with 
PWS, been prone to outbursts of temper in response to 
apparently minor frustrations or changes in routine, she 
made good progress after the move, which was planned and 
apparently welcomed by E. Because her outbursts of temper 
seemed more frequent premenstrually, she had been 
prescribed noresthisterone from the age of 20. 
After six months residence at the rehabilitation facility, E 
became increasingly suspicious and started to seek reassur-
ance that members of staff were not telephoning her parents 
to complain about her. Initially she was able to accept some 
reassurance that staff were not behaving in this way, but over 
the following six months she became increasingly resistant 
to reason or explanation, and eventually became convinced 
that staff were discussing her in a critical manner between 
themselves and in telephone conversations with her parents. 
A referral for a psychiatric opinion was made following 
advice from the Prader-Willi Syndrome Association (UK). 
When assessed, E was 1.47m tall and weighed 66.4kg 
(body mass index 30.74). She had fair hair and blue/grey 
eyes, and the dysmorphology typical of Prader-Willi 
syndrome. She also had small hands and feet (palm length 
9.5cm, mid finger length 6.1cm, foot length 19.2cm) and 
a cognitive impairment. E also had an articulation disor-
der, and communicated with a mixture of speech and 
makaton sign language. She had no hearing impairment. 
She was able to describe her problems and said that she 
was sure staff at the unit were making derogatory 
comments about her. She was especially concerned that 
the staff were talking to her parents by telephone, which 
she believed was happening several times each day. For 
this reason she was reluctant to leave groups of people, 
(eg. to go to bed in the evening). She also said that on one 
occasion she had heard her father talking about her when 
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she was talking to her mother on the telephone, at a time 
when her father was not present in the room with her 
mother. She may have experienced auditory hallucinations 
on other occasions but it was not possible to be certain 
about this, and auditory hallucinations did not seem to be 
a prominent feature of the disorder. E was unable to say 
why people should wish to discuss her with her parents but 
felt sure that this was happening, and that the comments 
were adverse. 
The staff reported that if E could hear clearly what people 
were saying to each other, there were rarely problems. If she 
could hear staff talking in an adjacent room, or when ambi-
ent noise made it difficult for her to distinguish what was 
being said, she would become very distressed and shout. 
This was a marked change from her behaviour and 
demeanour when she first moved to the unit. The allegations 
that staff had 'phoned or had discussed her' would often be 
associated with an outburst of temper, so that the frequency 
of temper 'tantrums' had increased markedly over the 
months before the assessment. 
E was not low in mood, and she had no consistent sleep 
disturbance or other features suggestive of an affective disor-
der. Her speech was rational, but poorly enunciated. She had 
no abnormal or inexplicable bodily sensations, and she did 
not describe or hint at passivity experiences. There had been 
no change in her memory or orientation, and her self-help 
skills were largely unchanged (there had been a slight dete-
rioration because she often interrupted tasks to accuse a 
member of staff of talking about her). 
The staff described a marked but gradual change in E's 
functioning as a result of her illness, and at the time of 
assessment her suspiciousness and abnormal beliefs were 
such that she was unable to engage in many of her usual 
activities. She had become more socially withdrawn than 
previously, but this was not a major problem. E was physi-
cally healthy and routine investigations, including thyroid 
function tests, did not show any abnormality. 
The disorder fulfilled ICD-10 Diagnostic Criteria for 
Research for delusional disorder (F22.0) or a provisional 
diagnosis of organic delusional disorder (F06.2) depending 
on whether Prader-Willi syndrome is regarded as a 
"systemic physical disorder known to cause cerebral 
dysfunction".13 This is discussed below. 
Treatment with oral flupenthixol (lmg daily for one week 
increasing to 2mg daily thereafter) was started. Over the 
following weeks E became much less distressed by her 
abnormal ideas, and sought reassurance far less often. She 
was again able to engage in day-to-day activities and to 
resume some of her previous leisure interests. The episodes 
of loss of temper, which had been more frequent and more 
severe while E had the abnormal ideas, returned to the 
pattern seen prior to the onset of the disorder. 
Chromosome 15 studies showed a deletion of 15 (q l l -
ql3) which was detectable with molecular techniques, but 
not visible cytogenetically. E's fair skin and hair colouring 
compared to the rest of her family probably results from this 
deletion.14 
At five month follow-up E remains much improved, with 
only occasional ideas that she is being talked about and with 
a marked improvement in her social functioning. Unfortu-
nately, she has gained weight (current weight 71.4kg). It is 
possible that treatment with antipsychotic medication has 
contributed to the weight gain. 
Discussion 
In addition to the three cases reported previously,12 there is 
a description of a 20 year old man with PWS who had two 
psychotic episodes in which delusions and hallucinations 
were prominent, with a full recovery. The authors concluded 
that: "Viewing the disorder cross-sectionally, it fits best 
within the group of schizophrenic psychoses with the 
predominant characteristic feature of paranoia. The way the 
illness developed, with the acute symptoms disappearing 
completely on two occasions, makes one think that the 
patient has an endogenous agitated depressive, paranoidly 
coloured disorder of the cycloid type".15 Other descriptions 
of cases or series of people with PWS mention psychotic 
symptoms, including a description of two (out of 40) people 
with PWS who had "hallucinations and withdrawal and 
required admission";16 a report of 12 out of 35 people with 
PWS who had "occasional auditory hallucinations";7 and a 
report of a 36 year old woman with mosaicism for del 15 
(q l l . l ql 1.2), hypothyroidism and hospital admissions 
because of "extreme restlessness, psychosis and disruptive 
behaviour which requires phenothiazine medication" which 
the authors felt was unrelated to her hypothyroidism." 
Jerome18 described a 31 year old woman with PWS and a 
rapid cycling bipolar affective disorder which responded to 
treatment with fluoxetine and lithium, and suggested that a 
previously reported case19 may also have had a bipolar disor-
der associated with PWS. A case of Prader-Willi syndrome 
associated with cycloid psychosis was presented at the Third 
International Symposium of the Society for the Study of 
Behavioural Phenotypes.20 
It is not possible to conclude that psychoses are more 
prevalent among people with PWS, or that there is a partic-
ular association between the two types of disorder, on the 
basis of isolated case reports. However, PWS is a relatively 
rare disorder, affecting about one in 15,000 people aged 0 to 
25 years21 and population-based studies would therefore be 
difficult to carry out. The most appropriate methodology 
would be to follow up children with PWS through adult life, 
and document abnormalities in behaviour and psychopathol-
ogy as they occur. No such study has so far been carried out, 
to the authors' knowledge. 
The association with psychotic symptoms may be due to 
chance, or to the effect of cognitive impairment (or other 
intervening or associated variables) rather than being 
specific to PWS. People with mental retardation have an 
increased prevalence of psychotic and other psychiatric 
disorders compared to the general population.22 The study of 
homogeneous groups of people with cognitive impairments 
(such as populations with PWS, fragile-X syndrome, Down 
syndrome, etc) is likely to shed light on the factors underly-
ing this increased risk. It has been noted that people with 
PWS have relative deficits in auditory/verbal information 
processing, and relative strengths in visual perception and 
visual/motor task performance,23 and this may be relevant to 
the pathogenesis of psychotic symptoms. A predisposition to 
symptoms such as ideas of reference, delusions and possibly 
auditory hallucinations may arise through auditory misper-
ception or dysfunctional auditory information processing. 
Such deficits may also partly explain the 'stubbornness' or 
lack of amenability to reason (presented aurally) which has 
been described in association with PWS. 
This patient's disorder is probably best viewed as an 
organic delusional disorder, although ICD-10 Research 
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Diagnostic Criteria only allow a provisional diagnosis to be 
made where it cannot be demonstrated that "there is recov-
ery from or significant improvement in the mental disorder 
following removal or improvement of the underlying 
presumed cause".13 The most appropriate classification of 
psychotic symptoms occurring in association with PWS will 
only be possible when more is known about their pathogen-
esis, and about the cerebral dysfunction occurring in PWS. 
This may in turn be facilitated by further research into the 
pattern of cognitive abilities and impairments seen in PWS, 
and the nature and extent of other mental and behavioural 
abnormalities associated with the condition. 
The woman reported here was referred specifically 
because one author (DC) has a special interest in psychoses 
and behaviour disorders associated with developmental 
disorders. The population of people with PWS with whom 
he is in contact is likely to be biased towards those with 
more behavioural and psychiatric morbidity. 
The authors therefore urge some caution when interpret-
ing this observation of a further case of psychotic symptoms 
associated with PWS. However, we hope that it may stimu-
late other reports of the association, if this is more common 
than previously recognised, and research into the pathogen-
esis of such symptoms. 
The improvement in quality of life following treatment 
was remarkable for this patient. It is important that psychotic 
symptoms are recognised and treated when they do occur in 
association with developmental disorders, and that they are 
differentiated from maladaptive or non-specific 'challeng-
ing' behaviours arising for other reasons, and with other 
implications for treatment. Prader-Willi syndrome is said by 
some carers to be associated with unusual sensitivity to the 
effects of some psychoactive medications, but there has been 
little research in this area. One study noted that six out of 42 
adults with PWS given psychoactive medication had 
medication withdrawn "due either to toxicity or ineffective-
ness",24 and another urged caution in the use of 
antipsychotics to treat non-psychotic behavioural abnormal-
ities associated with PWS.19 Low doses of psychotropic 
medications would therefore seem advisable when initiating 
treatment. 
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